Smart Pipeline Decisions: AI-Powered Indication Prioritization for Oncology TA
Background: In the current scenario, the competitive landscape of oncology TA, where innovation moves rapidly, pharma companies face intense pressure to optimize their pipeline investments. With hund ...
Mapping the Future: Identifying High-value Therapy Area Strategy for Emerging Markets
Background: In an evolving global disease landscape, identifying the right therapy areas or indication setting for investment is a strategic move that defines a company's growth trajectory, especiall ...
The Analogue Advantage: A Smarter Way to derive the market uptake and New Product revenue Forecast
Background: Launching a new therapy in the oncology space is one of the most complex and challenging in the pharma and biotech industries. With evolving treatment landscapes, shifting market dynamics ...